Biotech Company News Merck to Acquire Immune Design By Staff Reports 4 weeks ago Merck and Immune Design announced that the companies have entered into a definitive agreement under
Immunotherapies Immunotherapy can be effective in treating people with recurrent glioblastoma By Staff Reports 1 month ago A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before
Biotech Company News Bristol-Myers Squibb to Acquire Celgene By Staff Reports 2 months ago Bristol-Myers bulks up cancer portfolio with $74 billion Celgene deal (Reuters) – Bristol-Myers Squibb Co
cancer Cancer Discovery Cancer screening Immunotherapies Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study By Staff Reports 4 months ago A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating
Cancer Discovery Eureka Therapeutics Achieves Regression of Metastatic Liver Cancer Using T-Cell Therapy By Staff Reports 6 months ago Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing
cancer Cancer Discovery Combination Immunotherapy Shrinks Melanoma Brain Metastases By Staff Reports 7 months ago Combination immunotherapy shrank melanoma that has spread to the brain in more than half of
Breast Cancer Cancer Center of Kansas to Study Novel Cancer Immunotherapy in Advanced Breast Cancer By Staff Reports 7 months ago The Cancer Center of Kansas (CCK) has been added as a new clinical trial site
cancer Immunotherapies First In-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to be Launched By Staff Reports 7 months ago Stony Brook University, iCell Gene Therapeutics, and the University of Louisville, have received Food and
Cancer Discovery Researchers pinpoint new subtype of prostate cancer By Staff Reports 9 months ago Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype
Immunotherapies Peer Reviewed Paper: Novel Immunotherapy Actives CD4 Helper T Cells using HLA-Class II Molecules By Staff Reports 12 months ago The findings detailed in an upcoming peer-reviewed paper provide a rationale for the encouraging clinical
Biotechnology cancer Immunotherapies rare diseases Smart Bomb Virus Shows Promise as Brain Tumor Immunotherapy By Staff Reports 1 year ago A common cold virus engineered to attack the most common and deadly of brain tumors
Biotechnology Clinical Trials Gene Therapy Immunotherapies T Cell Therapy Shows Persistent Benefits in Young Leukemia Patients By Staff Reports 1 year ago CHOP Oncologists Update Analysis in Pivotal Global Trial of CAR T-Cell Treatment for Relapsed or
cancer Cancer Discovery Early Evidence of Efficacy and Safety Seen in Novel Targeted Immunotherapy By Staff Reports 1 year ago An immune-oncology focused biotechnology company, BriaCell, has provided a clinical update on its lead immunotherapy
Cell Therapy Clinical Trials Gene Therapy Immunotherapies Bioengineered Soft Microfibers Improve T-Cell Production By Staff Reports 1 year ago Columbia engineers bioengineer soft microfibers to improve T-cell production. T cells play a key role
Biotechnology Rare Melanoma Type Highly Responsive to Immunotherapy By Staff Reports 1 year ago Desmoplastic melanoma is a rare subtype of melanoma that is commonly found on sun-exposed areas,
Cancer Discovery BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer By Staff Reports 1 year ago BriaCell, an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, has provided a
Biotechnology Immunotherapies Phase III Immunotherapy Trial for Migraine Shows Positive Results By Staff Reports 1 year ago An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of
Biotechnology Gene Therapy Infectious Diseases Vaccines Discovery of key molecules involved in severe malaria By Staff Reports 1 year ago Malaria*1 is one of three major infectious diseases*2 affecting approximately 300 million people every year,
Biotechnology cancer Immunotherapies Cancer Immunotherapy May Get a Boost by Disabling Specific T Cells By Staff Reports 2 years ago Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now
Biotechnology Clinical Trials Gene Therapy Immunotherapies Exploring Immunotherapy for Carcinoid and Pancreatic Neuroendocrine Tumors By Staff Reports 2 years ago A clinical trial testing the immunotherapy drug pembrolizumab shows the drug to be well tolerated